160 related articles for article (PubMed ID: 29387220)
21. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
Chen W; Zhang Y; Fang Z; Qi W; Xu Y
Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
[TBL] [Abstract][Full Text] [Related]
22. Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13.
Lin YH; Tian Y; Wang JS; Jiang YG; Luo Y; Chen YT
Tumour Biol; 2015 Jul; ():. PubMed ID: 26201898
[TBL] [Abstract][Full Text] [Related]
23. Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
Xu G; Wei J; Huangfu B; Gao J; Wang X; Xiao L; Xuan R; Chen Z; Song G
Mol Carcinog; 2020 Nov; 59(11):1302-1316. PubMed ID: 33006223
[TBL] [Abstract][Full Text] [Related]
24. PTTG1 cooperated with GLI1 leads to epithelial-mesenchymal transition in esophageal squamous cell cancer.
Feng W; Xiaoyan X; Shenglei L; Hongtao L; Guozhong J
Oncotarget; 2017 Nov; 8(54):92388-92400. PubMed ID: 29190924
[TBL] [Abstract][Full Text] [Related]
25. High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma.
Wei C; Yang X; Xi J; Wu W; Yang Z; Wang W; Tang Z; Ying Q; Zhang Y
Mol Clin Oncol; 2015 Mar; 3(2):387-391. PubMed ID: 25798272
[TBL] [Abstract][Full Text] [Related]
26. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc.
Wang Y; Hu J; Chen C; Li Y
Open Life Sci; 2024; 19(1):20220813. PubMed ID: 38465336
[TBL] [Abstract][Full Text] [Related]
27. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
[TBL] [Abstract][Full Text] [Related]
28. Bisphenol A promotes breast cancer cell proliferation by driving miR-381-3p-PTTG1-dependent cell cycle progression.
Deng P; Tan M; Zhou W; Chen C; Xi Y; Gao P; Ma Q; Liang Y; Chen M; Tian L; Xie J; Liu M; Luo Y; Li Y; Zhang L; Wang L; Zeng Y; Pi H; Yu Z; Zhou Z
Chemosphere; 2021 Apr; 268():129221. PubMed ID: 33352510
[TBL] [Abstract][Full Text] [Related]
29. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
Ito T; Shimada Y; Kan T; David S; Cheng Y; Mori Y; Agarwal R; Paun B; Jin Z; Olaru A; Hamilton JP; Yang J; Abraham JM; Meltzer SJ; Sato F
Cancer Res; 2008 May; 68(9):3214-24. PubMed ID: 18451147
[TBL] [Abstract][Full Text] [Related]
30. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
Hu X; Yang F; Mei H
J Orthop Sci; 2024 Jan; 29(1):306-314. PubMed ID: 36414514
[TBL] [Abstract][Full Text] [Related]
31. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.
Meng C; Zou Y; Hong W; Bao C; Jia X
Mol Med; 2020 Apr; 26(1):33. PubMed ID: 32272902
[TBL] [Abstract][Full Text] [Related]
33. PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.
Yoon CH; Kim MJ; Lee H; Kim RK; Lim EJ; Yoo KC; Lee GH; Cui YH; Oh YS; Gye MC; Lee YY; Park IC; An S; Hwang SG; Park MJ; Suh Y; Lee SJ
J Biol Chem; 2012 Jun; 287(23):19516-27. PubMed ID: 22511756
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of PTTG1 and Its Methylation in Lung Adenocarcinoma.
Bai L; Li LH; Liang J; Li EX
J Oncol; 2022; 2022():3507436. PubMed ID: 35251171
[TBL] [Abstract][Full Text] [Related]
35. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
[TBL] [Abstract][Full Text] [Related]
36. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
37. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses.
Long J; Zhang Z; Liu Z; Xu Y; Ge C
Oncol Lett; 2016 Feb; 11(2):1391-1397. PubMed ID: 26893748
[TBL] [Abstract][Full Text] [Related]
38. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
39. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
